Effect of oral combination therapy with mexiletine and quinidine on left and right ventricular function
- 1 May 1988
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 115 (5) , 1030-1036
- https://doi.org/10.1016/0002-8703(88)90072-5
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Mexiletine-quinidine combination: Electrophysiologic correlates of a favorable antiarrhythmic interaction in humansJournal of the American College of Cardiology, 1987
- Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery diseaseThe American Journal of Cardiology, 1985
- Effects of flecainide on ventricular function: Clinical and experimental correlationsThe American Journal of Cardiology, 1984
- Determinants of Survival in Patients with Ventricular TachyarrhythmiasNew England Journal of Medicine, 1983
- Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.Circulation, 1983
- Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsThe American Journal of Cardiology, 1982
- Congestive Heart Failure Caused by Oral DisopyramideNew England Journal of Medicine, 1980
- Ventricular premature beats and anatomically defined coronary heart diseaseThe American Journal of Cardiology, 1977
- Haemodynamic Changes Following Separate and Combined Administration of Beta-Blocking Drugs and QuinidineEuropean Journal of Clinical Investigation, 1971
- The influence of quinidine and procaine amide on myocardial contractility in vivoThe American Journal of Cardiology, 1960